Pugh Gemma, Young Lauren, Yiallouridou Christina, Hart Dawn, Dean Karen, Danby Robert
Anthony Nolan, 2 Heathgate Pl, London, NW3 2NU, UK.
Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Support Care Cancer. 2025 Jun 10;33(7):562. doi: 10.1007/s00520-025-09578-4.
The purpose of this study was to explore how haematopoietic cell transplantation (HCT) recipients define quality of life (QoL) and the impact of receiving a stem cell transplant.
Qualitative one-on-one semi-structured interviews were conducted with patients aged ≥ 18 years who had received HCT. Interviews were audio recorded, transcribed verbatim and thematically analysed using NVivo 14 software. A patient advisory group (n = 6 patients) co-designed the qualitative interview study and were involved in developing the initial coding framework and themes generated.
Data saturation was reached after 21 interviews (median age 45 years, range 26-71 years). Participants described a change in perspective about the meaning of QoL post-transplant and having to adapt to a 'new normal'. Specifically, patients described how being immunocompromised post HCT negatively affected social, emotional and occupational QoL. Participants described facing a new, unfamiliar reality post-transplant and a feeling of being un-prepared for the long-term impact of HCT.
Patients require support to cope with continuously changing physical, social, emotional and occupational challenges. Supportive care interventions should be designed to address the impact of being immunocompromised.
本研究旨在探讨造血细胞移植(HCT)受者如何定义生活质量(QoL)以及接受干细胞移植的影响。
对年龄≥18岁且接受过HCT的患者进行定性一对一的半结构化访谈。访谈进行录音,逐字转录,并使用NVivo 14软件进行主题分析。一个患者咨询小组(6名患者)共同设计了定性访谈研究,并参与制定初始编码框架和生成的主题。
在进行21次访谈后达到数据饱和(中位年龄45岁,范围26 - 71岁)。参与者描述了移植后对生活质量含义的看法变化,以及不得不适应“新常态”。具体而言,患者描述了HCT后免疫功能低下如何对社交、情感和职业生活质量产生负面影响。参与者描述了移植后面临新的、不熟悉的现实,以及对HCT的长期影响毫无准备的感觉。
患者需要支持来应对不断变化的身体、社交、情感和职业挑战。支持性护理干预措施应旨在解决免疫功能低下的影响。